Gene · 4005
Papers2,403
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,403
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping. | Viruses | 2025 | 40872751 | PubTator, text mining | PubMed |
| Modeling integration site data for safety assessment with MELISSA. | Nat Commun | 2025 | 40849411 | PubTator, text mining | PubMed |
| Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High-Risk Diffuse Large B Cell Lymphoma. | Hematol Oncol | 2025 | 40847617 | PubTator, text mining | PubMed |
| Endothelial transdifferentiation of glioma stem cells: a literature review. | Acta Neuropathol Commun | 2025 | 40841988 | PubTator, text mining | PubMed |
| Changes in cellular composition shape the inductive properties of Hensen's Node. | Nat Commun | 2025 | 40841542 | PubTator, text mining | PubMed |
| Mechanisms of Cancer Cell Lymphatic Endothelialization in Tumor Lymphangiogenesis and Metastasis: A Comprehensive Review. | J Inflamm Res | 2025 | 40809467 | PubTator, text mining | PubMed |
| hInGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicity. | Gene Ther | 2025 | 40664913 | PubTator, text mining | PubMed |
| LMO2 confers value as a potential immunotherapy marker in pan-cancer analysis and inhibits progression of Clear Cell Renal Cell Carcinoma. | Transl Oncol | 2025 | 40344914 | PubTator, text mining | PubMed |
| Specific expression and common potential therapeutic drugs in different brain regions of major depressive disorder patients: bioinformatics analysis. | J Affect Disord | 2025 | 40286923 | PubTator, text mining | PubMed |
| Single-cell profiling reveals monocyte heterogeneity and association with liver fibrosis in patients with chronic HBV. | Hepatol Commun | 2025 | 40227083 | PubTator, text mining | PubMed |
| Co-occurrence of thymoma and acute T-lymphoblastic leukemia/lymphoma: a case report and literature review. | Mediastinum | 2025 | 40224340 | PubTator, text mining | PubMed |
| Cytogenomic and Clinicopathologic Comparison of MYC-Positive and MYC-Negative High-Grade B-Cell Lymphoma With 11q Aberration in the Context of Other Aggressive Lymphomas With MYC Rearrangement. | Mod Pathol | 2025 | 40222649 | PubTator, text mining | PubMed |
| Competing dynamic gene regulatory networks involved in fibroblast reprogramming to hematopoietic progenitor cells. | Stem Cell Reports | 2025 | 40185089 | PubTator, text mining | PubMed |
| Single-cell transcriptomics analysis reveals that the tumor-infiltrating B cells determine the indolent fate of papillary thyroid carcinoma. | J Exp Clin Cancer Res | 2025 | 40069827 | PubTator, text mining | PubMed |
| Repurposing the Whole Expression Transcriptome Assay for the Genetic Diagnosis of T-Cell Acute Lymphoblastic Leukemia and Lymphoma. | J Mol Diagn | 2025 | 39984035 | PubTator, text mining | PubMed |
| The common murine retroviral integration site activating Hhex marks a distal regulatory enhancer co-opted in human early T-cell precursor leukemia. | J Biol Chem | 2025 | 39880094 | PubTator, text mining | PubMed |
| Analysis of the effect of LMO2 on indicating CD8+ T-lymphocyte infiltration in pan-cancers. | Biochem Biophys Rep | 2025 | 39686960 | PubTator, text mining | PubMed |
| Combined immunohistochemical profile CD10/LMO2/MYC is a useful tool to screen MYC rearrangements in aggressive large B-cell lymphomas. | Virchows Arch | 2025 | 39436442 | PubTator, text mining | PubMed |
| Are we there yet? Exploring astrocyte heterogeneity one cell at a time. | Glia | 2025 | 39308429 | PubTator, text mining | PubMed |
| Pareto task inference analysis reveals cellular trade-offs in diffuse large B-Cell lymphoma transcriptomic data. | Front Syst Biol | 2024 | 40809150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4005/papers?page=3